RAP 0.00% 20.5¢ resapp health limited

Milestones for 2016 Obtained approval to enroll adult patients...

  1. 173 Posts.
    Milestones for 2016
    Obtained approval to enroll adult patients at second hospital site, The Wesley Hospital (Q1) ¨
    Reported interim results from pediatric study demonstrating superiority to stethoscope for lower respiratory tract disease (Q1) ¨
    Secured partnership with global humanitarian organisation for developing world trial (Q1) ¨
    Successfully held Pre-Submission meeting with the US FDA (Q1) ¨
    Report updated results from pediatric clinical study (Q1) ¨
    Report preliminary results from adult clinical study (Q2) ¨
    Initiate pivotal clinical study in US and Australia (Q2) ¨
    File de novo premarket submission with FDA for first ResApp product (mid-year) ¨
    FDA marketing approval for first ResApp product (Q4)


    i think it really needs to hold this 255/260 point or could take a bit of a dive.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.